Bernhard Reis
Basel, BS 4070, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
In vitro and in vivo derived macrophages occupy distinct phenotypic states.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.
Journal: Nature cancer
Published: December 19, 2024
A randomized, double-blind, placebo-controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease.
Journal: Clinical and translational science
Published: February 12, 2024
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Journal: Frontiers in immunology
Published: August 29, 2023
Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2023
Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2020
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 23, 2019
Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.
Journal: Arthritis research & therapy
Published: February 21, 2019
Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.
Journal: BMC cancer
Published: November 20, 2018
Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages.
Journal: Biochemical pharmacology
Published: July 05, 2017
Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S.
Journal: Frontiers in immunology
Published: April 02, 2017
Last Updated: 09/26/2026